Treatment of rheumatoid arthritis with mammal beta defensins
US8232248B2 · kind B2 · utility
5Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 17, 2009 |
| Grant date | Jul 31, 2012 |
| Priority date | — |
| Expiry date | Dec 6, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to treatment of rheumatoid arthritis with mammal beta defensins.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.